ACTION-Coeur, randomized controlled trials

ABYSS

Terminée

Phase 4 trial, evaluating the interest of betablocking treatment in the long term treatment of non-complicated myocardial infarct.

+

ADRIFT

Terminée

Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure

+

ALPHEUS

Terminée

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS) : a randomised, open-label, phase 3b trial

+

ARAMIS

Terminée

Evaluation of Anakinra versus placebo in treatment of acute myocarditis and evaluation of the contuity of the reference treatment with IEC in patients without ventricular dysfunction ventriculaire.

+

ATLANTIS

Terminée

Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis

+

AGENT

Terminée

Transfer of the Serca2a gene via a AAV1 type vector (adeno-associated viral 1) for treating severe cardiac insufficiency.

+

AEGEAN

Terminée

The study purpose is to assess the impact of an educational program on patient adherence in patients taking Apixaban for SPAF at 24 weeks

+

ANTARCTIC

Terminée

Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome

+

AMPHORE

Terminée

A phase I, randomized, open-label, crossover study to evaluate the antiplatelet effect of intravenous clopidogrel (MDCO-157) versus oral clopidogrel

Randomized Trials

ABYSS

ADRIFT

ALPHEUS

ARAMIS

ATLANTIS

AGENT

AEGEAN

ANTARCTIC

AMPHORE